Evidence map›Paper›PMID 37233648›Full record

ArticleMetabolites2023

Metabolomic Profiling of Bipolar Disorder by

Katarina Simić, Zoran Miladinović, Nina Todorović, Snežana Trifunović, Nataša Avramović, Aleksandra Gavrilović, Silvana Jovanović, Dejan Gođevac, Ljubodrag Vujisić, Vele Tešević and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Metabolites, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Biomarkers of bipolar disorder in omics and neuroimaging.Journal of pharmaceutical analysis · 2025
    Review
  5. Review
  6. Review
  7. LC-HRMS Lipidomic Fingerprints in Serbian Cohort of Schizophrenia Patients.International journal of molecular sciences · 2024
    Article
  8. Untargeted Lipidomics Study of Bipolar Disorder Patients in Serbia.International journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Katarina SimićInstitute of Chemistry, Technology and Metallurgy, National Institute, University of Belgrade, Studentski trg 12-16, 11000 Belgrade, Serbia.ORCID 0000-0001-5060-8936
Zoran MiladinovićInstitute of General and Physical Chemistry, Studentski trg 12-16, 11158 Belgrade, Serbia.ORCID 0000-0003-2086-9064
Nina TodorovićInstitute of Chemistry, Technology and Metallurgy, National Institute, University of Belgrade, Studentski trg 12-16, 11000 Belgrade, Serbia.
Snežana TrifunovićUniversity of Belgrade - Faculty of Chemistry, Studentski trg 12-16, 11000 Belgrade, Serbia.
Nataša AvramovićUniversity of Belgrade - Faculty of Medicine, Institute of Medical Chemistry, Višegradska 26, 11000 Belgrade, Serbia.ORCID 0000-0001-7338-0161
Aleksandra GavrilovićSpecial Hospital for Psychiatric Diseases "Kovin", Cara Lazara 253, 26220 Kovin, Serbia.
Silvana JovanovićSpecial Hospital for Psychiatric Diseases "Kovin", Cara Lazara 253, 26220 Kovin, Serbia.
Dejan GođevacInstitute of Chemistry, Technology and Metallurgy, National Institute, University of Belgrade, Studentski trg 12-16, 11000 Belgrade, Serbia.ORCID 0000-0002-0555-581X
Ljubodrag VujisićUniversity of Belgrade - Faculty of Chemistry, Studentski trg 12-16, 11000 Belgrade, Serbia.ORCID 0000-0001-7625-7484
Vele TeševićUniversity of Belgrade - Faculty of Chemistry, Studentski trg 12-16, 11000 Belgrade, Serbia.
Ljubica TasicInstitute of Chemistry, Organic Chemistry Department, State University of Campinas, Campinas 13083-970, SP, Brazil.ORCID 0000-0003-2930-7332
Boris MandićUniversity of Belgrade - Faculty of Chemistry, Studentski trg 12-16, 11000 Belgrade, Serbia.
University of Belgrade · RSInstitute of General and Physical Chemistry · RSUniversidade Estadual de Campinas (UNICAMP) · BR

Funding

Ministry of Education and Science of the Republic of Serbia 451-03-68/2022-14/200168, 451-03-68/2022-14/200026 and 451-03-68/2022-14/200051Organisation for the Prohibition of Chemical Weapons L/ICA/ICB-217652/18 and L/ICA/ICB-108/21
6 · The paper itself

Abstract

Bipolar disorder (BD) is a brain disorder that causes changes in a person's mood, energy, and ability to function. It has a prevalence of 60 million people worldwide, and it is among the top 20 diseases with the highest global burden. The complexity of this disease, including diverse genetic, environmental, and biochemical factors, and diagnoses based on the subjective recognition of symptoms without any clinical test of biomarker identification create significant difficulties in understanding and diagnosing BD. A

Indexed as

biomarkersbipolar disorderchemometricsmetabolomicsNMRserum metabolites

Identifiers

PMID37233648
PMCPMC10223505
OpenAlexW4367310853

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.